Nishibe H - Search Results

1

Phospholipase D family member 4, a transmembrane glycoprotein with no phospholipase D activity, expression in spleen and early postnatal microglia.

Yoshikawa F, Banno Y, Otani Y, Yamaguchi Y, Nagakura-Takagi Y, Morita N, Sato Y, Saruta C, Nishibe H, Sadakata T, Shinoda Y, Hayashi K, Mishima Y, Baba H, Furuichi T. Yoshikawa F, et al. Among authors: nishibe h. PLoS One. 2010 Nov 11;5(11):e13932. doi: 10.1371/journal.pone.0013932. PLoS One. 2010. PMID: 21085684 Free PMC article.

2

Cerebellar development transcriptome database (CDT-DB): profiling of spatio-temporal gene expression during the postnatal development of mouse cerebellum.

Sato A, Sekine Y, Saruta C, Nishibe H, Morita N, Sato Y, Sadakata T, Shinoda Y, Kojima T, Furuichi T. Sato A, et al. Among authors: nishibe h. Neural Netw. 2008 Oct;21(8):1056-69. doi: 10.1016/j.neunet.2008.05.004. Epub 2008 Jun 4. Neural Netw. 2008. PMID: 18603407

3

Systematizing and cloning of genes involved in the cerebellar cortex circuit development.

Furuichi T, Shiraishi-Yamaguchi Y, Sato A, Sadakata T, Huang J, Shinoda Y, Hayashi K, Mishima Y, Tomomura M, Nishibe H, Yoshikawa F. Furuichi T, et al. Among authors: nishibe h. Neurochem Res. 2011 Jul;36(7):1241-52. doi: 10.1007/s11064-011-0398-1. Epub 2011 Jan 18. Neurochem Res. 2011. PMID: 21243430 Review.

4

Cellular-resolution gene expression profiling in the neonatal marmoset brain reveals dynamic species- and region-specific differences.

Kita Y, Nishibe H, Wang Y, Hashikawa T, Kikuchi SS, U M, Yoshida AC, Yoshida C, Kawase T, Ishii S, Skibbe H, Shimogori T. Kita Y, et al. Among authors: nishibe h. Proc Natl Acad Sci U S A. 2021 May 4;118(18):e2020125118. doi: 10.1073/pnas.2020125118. Proc Natl Acad Sci U S A. 2021. PMID: 33903237 Free PMC article.

5

Digital gene atlas of neonate common marmoset brain.

Shimogori T, Abe A, Go Y, Hashikawa T, Kishi N, Kikuchi SS, Kita Y, Niimi K, Nishibe H, Okuno M, Saga K, Sakurai M, Sato M, Serizawa T, Suzuki S, Takahashi E, Tanaka M, Tatsumoto S, Toki M, U M, Wang Y, Windak KJ, Yamagishi H, Yamashita K, Yoda T, Yoshida AC, Yoshida C, Yoshimoto T, Okano H. Shimogori T, et al. Among authors: nishibe h. Neurosci Res. 2018 Mar;128:1-13. doi: 10.1016/j.neures.2017.10.009. Epub 2017 Oct 27. Neurosci Res. 2018. PMID: 29111135

6

Prediction of Corresponding Dose of Transdermal Blonanserin to Oral Dose Based on Dopamine D2 Receptor Occupancy: Unique Characteristics of Blonanserin Transdermal Patch.

Tomita Y, Takagaki T, Kitamura A, Wada E, Nishibe H, Tateno A, Okubo Y. Tomita Y, et al. Among authors: nishibe h. J Clin Psychopharmacol. 2022 May-Jun 01;42(3):260-269. doi: 10.1097/JCP.0000000000001545. Epub 2022 Apr 5. J Clin Psychopharmacol. 2022. PMID: 35384896 Free PMC article.

7

Pharmacokinetic Evaluation of Blonanserin Transdermal Patch: Population Analysis and Simulation of Plasma Concentration and Dopamine D₂ Receptor Occupancy in Clinical Settings.

Kitamura A, Takagaki T, Nemoto D, Tomita Y, Nishibe H, Kakuyama H. Kitamura A, et al. Among authors: nishibe h. J Clin Pharmacol. 2021 Aug;61(8):1069-1080. doi: 10.1002/jcph.1835. Epub 2021 Mar 31. J Clin Pharmacol. 2021. PMID: 33599975 Clinical Trial.

8

Striatal Dopamine D2 Receptor Occupancy Induced by Daily Application of Blonanserin Transdermal Patches: Phase II Study in Japanese Patients With Schizophrenia.

Nishibe H, Tateno A, Sakayori T, Yamamoto M, Kim W, Kakuyama H, Okubo Y. Nishibe H, et al. Int J Neuropsychopharmacol. 2021 Feb 15;24(2):108-117. doi: 10.1093/ijnp/pyaa071. Int J Neuropsychopharmacol. 2021. PMID: 32936897 Free PMC article. Clinical Trial.

9

Prediction methods of drug-drug interactions of non-oral CYP3A4 substrates based on clinical interaction data after oral administrations - Validation with midazolam, alfentanil, and verapamil after intravenous administration and prediction for blonanserin transdermal patch.

Tomita Y, Yahata M, Hashimoto M, Nishimuta H, Kawaguchi H, Matsushita H, Kitamura A, Nishibe H, Natsui K, Watanabe T. Tomita Y, et al. Among authors: nishibe h. Drug Metab Pharmacokinet. 2020 Aug;35(4):345-353. doi: 10.1016/j.dmpk.2020.03.006. Epub 2020 Apr 27. Drug Metab Pharmacokinet. 2020. PMID: 32660818

10

Mizagliflozin, a novel selective SGLT1 inhibitor, exhibits potential in the amelioration of chronic constipation.

Inoue T, Takemura M, Fushimi N, Fujimori Y, Onozato T, Kurooka T, Asari T, Takeda H, Kobayashi M, Nishibe H, Isaji M. Inoue T, et al. Among authors: nishibe h. Eur J Pharmacol. 2017 Jul 5;806:25-31. doi: 10.1016/j.ejphar.2017.04.010. Epub 2017 Apr 11. Eur J Pharmacol. 2017. PMID: 28410751

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

30 results

Search Page

Filters